Health care product giant Johnson & Johnson is adding to its growing list of recalls this year -- this time a dozen types of Mylanta and one Alternagel antacid.
The wholesale and retail level recall was not done because of "adverse effects," the company said, but because an internal review showed the bottles failed to note the alcohol content of some flavoring agents.
"Certain flavoring agents contribute small (less than 1 percent) amounts of alcohol," the company said on the Mylanta website. "It is unlikely that use of these products will cause either absorption or alcohol sensitivity related adverse events."
CLICK HERE to see the recall announcement and which products are being recalled.
The recall affects as many as 12 million bottles of Mylanta and 85,000 bottles of Alternagel, according to a Reuters report.
Johnson & Johnson advised that there was no consumer safety concern related to the recall, and the products can still be used as directed.
It's yet another blow to the company whose manufacturer has already made more than half a dozen recalls this year alone, including the largest recall in children's medicine history.
Controversial Year for Johnson & Johnson
Only last month, Johnson & Johnson voluntarily recalled some of its Tylenol 8 Hour Caplets after consumers complained of a strange, musty color.
Back in July, McNeil announced a recall of 21 different product lots, including Children's Tylenol, Benadryl and Motrin.
In December 2009 and January 2010, McNeil recalled nearly 60 million bottles of Tylenol Arthritis Relief Caplets and a number of other products after consumers complained of stomach problems linked to the same chemical.
And in the largest recall of children's medicine in history, Johnson & Johnson pulled more than 136 million bottles of Tylenol, Motrin, Zyrtec and Benadryl -- more than 40 products in all -- in April.
In September, Johnson & Johnson's CEO Bill Weldon took responsibility for the company's multiple recalls.
ABC News' Kim Carollo contributed to this report.